Akseli Hemminki

Akseli Hemminki serves as Chief Executive Officer at TILT Biotherapeutics Ltd. TILT Biotherapeutics Ltd operates in the research sector with approximately 28.0 employees. TILT Biotherapeutics Ltd generates annual revenue of 4000000.0. To date, TILT Biotherapeutics Ltd has raised 44202988.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at TILT Biotherapeutics Ltd.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 YouTube Apache Mobile Friendly Typekit AI

oncolytic viruses solid tumors cancer immunotherapy oncoimmunology tcell therapy immune checkpoint inhibitors biotechnology research oncolytic immunotherapy tilt-123 cancer treatment t-cell stimulation cytokine therapy adenoviral vector tumor microenvironment checkpoint inhibitors car t therapy immuno-oncology phase 1 clinical trials clinical pipeline biotechnology tumor-infiltrating lymphocytes intravascular administration immune response enhancement cancer vaccines antitumor efficacy biologics cancer immunotherapy clinical research cancer therapeutics il-2 tnf alpha chimeric adenovirus safety profile combination therapies systemic delivery preclinical models cancer cell selectivity biomedical innovation scientific publications research & development university collaboration european innovation council business finland patent portfolio market potential targeted cancer therapy molecular profiling immune system modulation therapeutic strategies intratumoral injection investor relations business development clinical advancements future of immunotherapy b2b

AH

Akseli Hemminki Chief Executive Officer at TILT Biotherapeutics Ltd

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Akseli Hemminki in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at TILT Biotherapeutics Ltd.

Akseli Hemminki's Position in the MessageCEO Database

• •Akseli Hemminki is 1 of 2 verified executive contacts we track at TILT Biotherapeutics Ltd.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •42 verified contacts work at research companies in the 28.0 employee range (same size as TILT Biotherapeutics Ltd).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Akseli Hemminki directly?

Akseli Hemminki's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at TILT Biotherapeutics Ltd. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Akseli Hemminki work for?

Akseli Hemminki is Chief Executive Officer at TILT Biotherapeutics Ltd, a company in the research sector with 28.0 employees.

Can I pitch or sell to Akseli Hemminki?

As Chief Executive Officer at TILT Biotherapeutics Ltd, Akseli Hemminki is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Akseli Hemminki directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Akseli Hemminki in?

Akseli Hemminki works in the research industry as Chief Executive Officer at TILT Biotherapeutics Ltd. MessageCEO provides verified contact information for executives across all major industries.

Is Akseli Hemminki's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Akseli Hemminki's profile is kept up-to-date with the latest available information.

Last updated: June 23, 2026